Tofersen - Biogen/Ionis Pharmaceuticals
At a glance
- Drug Originator Center for Neurologic Study; Isis Pharmaceuticals; Ludwig Institute for Cancer Research
- Drug Licenced by Biogen
- Drug Class Antisense oligonucleotides
- Mechanism of Action Gene silencing; Superoxide dismutase 1 expression inhibitors
- USA Patent Applicants BIOGEN MA
- USA Patents 3
- NDAs 1
- International Patents 65
Table of Contents
Disclaimer